Sheau-Chiann Chen Selected Research

congenital Melanocytic nevus syndrome

11/2015	Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling.
8/2015	Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sheau-Chiann Chen Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 01/2016
9	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2017
6	Melanoma (Melanoma, Malignant) 01/2022 - 06/2016
5	Retinoblastoma (Glioblastoma, Retinal) 01/2022 - 01/2021
3	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2017
2	Rheumatoid Arthritis 01/2022 - 06/2021
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 06/2021
2	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2018
2	Retinal Degeneration 11/2021 - 01/2021
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2016
2	Triple Negative Breast Neoplasms 01/2020 - 08/2017
2	Neutropenia 01/2019 - 08/2017
2	congenital Melanocytic nevus syndrome 11/2015 - 08/2015
1	Inflammation (Inflammations) 01/2022
1	Insulin Resistance 01/2022
1	Lymphedema (Milroy Disease) 01/2022
1	Pain (Aches) 01/2022
1	Lipedema 01/2022
1	Pathologic Constriction (Stenosis) 12/2021
1	Cytopenia 01/2021
1	Toxic Optic Neuropathy 01/2021
1	Cytokine Release Syndrome 10/2020
1	COVID-19 10/2020
1	Infections 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Cognitive Dysfunction 01/2020
1	Disease Progression 01/2020
1	Open Bite (Openbite) 01/2019
1	Bronchiolitis Obliterans Syndrome 01/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Edema (Dropsy) 01/2019
1	Exanthema (Rash) 01/2019

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
6	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 01/2019
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 08/2015
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
4	Retinaldehyde (Retinal)IBA 01/2022 - 01/2021
4	Immune Checkpoint InhibitorsIBA 05/2021 - 01/2020
3	Estrogen ReceptorsIBA 01/2022 - 01/2017
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 01/2017
2	Cyclin D1IBA 01/2022 - 01/2019
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2022 - 01/2019
2	ChemokinesIBA 06/2021 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2021 - 08/2017
2	Pharmaceutical PreparationsIBA 01/2021 - 10/2017
2	Chemokine ReceptorsIBA 01/2021 - 10/2018
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	GenieIBA 01/2022
1	AcetaldehydeIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	Malondialdehyde (Propanedial)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	SodiumIBA 01/2022
1	Notch1 ReceptorIBA 01/2022
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 12/2021
1	Proton Pump InhibitorsIBA 12/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2021
1	Histone Deacetylase InhibitorsIBA 11/2021
1	belinostatIBA 11/2021
1	CalciumIBA 06/2021
1	MicroRNAs (MicroRNA)IBA 06/2021
1	gedatolisibIBA 05/2021
1	AlpelisibIBA 05/2021
1	copanlisibIBA 05/2021
1	dabrafenibIBA 01/2021
1	SolutionsIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Vincristine (Oncovin)FDA LinkGeneric 01/2021
1	Anti-Idiotypic AntibodiesIBA 01/2021
1	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Biological ProductsIBA 01/2021
1	trametinibIBA 01/2021
1	15-keto-13,14-dihydroprostaglandin F2alpha (PGFM)IBA 01/2021
1	tocilizumab (atlizumab)FDA Link 10/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2020
1	enzalutamideIBA 01/2020
1	2-(aminomethyl)phenolIBA 01/2020
1	PhosphoproteinsIBA 01/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2020
1	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	somatostatin receptor 2IBA 01/2019

Therapy/Procedure

11	Therapeutics 01/2022 - 06/2016
4	Drug Therapy (Chemotherapy) 11/2021 - 01/2021
3	Immunotherapy 01/2021 - 06/2016
2	Precision Medicine 01/2017 - 01/2016
1	Conservative Treatment 01/2022
1	Musculoskeletal Manipulations (Manipulative Therapy) 01/2022
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2022
1	Anesthesia 01/2021
1	Intravitreal Injections 01/2021
1	Injections 01/2021
1	Photopheresis 01/2019